Trouble reading this? Click Here. Send to a Friend
Skin Inc's e-newsletter

This Week's Top Industry News

Global Dominance in Facial Injectables, Allergan, Challenged
Botulinum toxin According to Millennium Research Group (MRG), a global authority on medical technology market intelligence, Allergan, continues to dominate the global facial injectable market, but is facing increasing competition from a growing number of competitors.
Study: Inflammation and Oxidative Stress Caused by Free Radicals in Adult Acne
Adult acne According to Laser and Cosmetic Dermatology specialist, Whitney Bowe, MD, antioxidants help block acne-causing free radicals.
Promising Results in Clinical Study for Acne Drug Candidate
Acne drug Novan Therapeutics announced results from a recent clinical trial demonstrating that nitric oxide-releasing drug candidate SB204 reduces colonization of the acne-causing bacteria Propionibacterium acnes (P. acnes) in the skin of healthy volunteers.

Suppress and Address Hyperpigmentation in Chemo Patients; Correcting Skin Conditions on the Scalp

WEB EXCLUSIVE: The Other Skin—Introducing the Scalp to Esthetics
Scalp treatments By: Rhonda Allison
WEB EXCLUSIVE: Are skin care professionals missing an opportunity by not treating the skin north of the forehead? If you subscribe to the notion that the scalp, too, is indeed skin, then the answer is “yes.”
Hyperpigmentation: A Key Side Effect of Chemotherapy
By: Jennifer Linder, MD
Once clients have successfully completed their cancer treatments, helping them to reclaim healthy skin can be a great emotional support.

Featured Event

Aug 24-26, 2013 | San Jose, CA, USA
Face & Body Northern California